ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic

THERAPEUTIC CLASS

ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic

The European Society of Cardiology - Organizational Body;

The SARS-CoV-2 causing COVID-19 has reached pandemic levels since March 2020. In the absence of vaccines or curative medical treatment, COVID-19 exerts an unprecedented global impact on public health and health care delivery. Owing to the unexpected need for large capacities of intensive care unit (ICU) beds with the ability to provide respiratory support and mechanical ventilation, temporary redistribution and reorganization of resources within hospitals have become necessary with relevant consequences for all medical specialties

Availability

Location name is not set Location name is not set

REQj4498-1

Available

Detail Information

Series Title: -
Call Number: -
Publisher: : .,
Collation: -
Language: English
ISBN/ISSN: -
Classification: NONE
Content Type: LITERATURE
Media Type: -
Carrier Type: -
Edition: -
Subject(s): Diviti
Fibrion
Vaclo
Clotix
Cardiovascular & Hematopoeiteic System
Briclot
Specific Detail Info: The European Society of Cardiology 2020
Statement of Responsibility: -

Other version/related

No other version available

File Attachment

Read Here

Comments

You must be logged in to post a comment